Mission Statement:
To improve the lives of alpha-1-antitrypsin deficient individuals and their families through research and service by:

1. Developing new therapies that target lung and liver disease associated with alpha-1-antitrypsin deficiency using a combination of basic and clinical research
2. Removing significant impediments to research by developing shared resources
3. Developing and utilizing cutting edge technologies to improve the early identification of individuals with alpha-1-antitrypsin deficiency
4. Providing clinics devoted to the care of alpha-1-antitrypsin deficient individuals with lung and liver disease.